3 Insulin resistance in type 1 diabetes Insulin resistance is associated with micro- and macrovascular complications in patients with T1D (28)
6,7,8,9,10,16 Indeed, GLP-1 receptor (GLP-1R) agonists, such as liraglutide and semaglutide, are approved for the treatment of both type 2 diabetes (T2D) and obesity
This proportional muscle loss is consistent with weight loss from any cause, including dietary restriction or bariatric surgery, but the rapidity of weight loss with these medications may make this effect more clinically apparent
Understanding proper technique from the outset reduces anxiety and minimizes the risk of injection-related complications
A person may feel better, eat more consistently, or improve protein intake while the scale temporarily stays flat
Content Outline Akkermansia muciniphila A Key Player in the GutGLP-1 Axis Bifidobacterium species Modulating GLP-1 via SCFA and HMO Metabolism Lactobacillus species Probiotic Strains Linked to Higher GLP-1 Levels Emerging GLP-1Linked Species: Faecalibacterium and Roseburia Prebiotics, HMOs, and Dietary Compounds That Enhance GLP-1-Producing Bacteria Why GLP-1 Matters for Metabolic and Gut Health Glucagon-like peptide-1 (GLP-1) has made headlines in recent years thanks to weight loss GLP injections
